You just read:

CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S Prepares for Regulatory Filing of Arimoclomol in U.S. for Niemann-Pick Disease Type C

News provided by

CytRx Corporation

Jul 30, 2019, 09:00 ET